TLGs shown are illustrative and are meant to indicate platform capability and readiness.
Welcome Dr. Anand Sharma
What would you like to do today?
Professor & HOD
Urology & Radiation Oncology
AIIMS New Delhi
347
cohort records
63
active care gap flags
Governed Evidence Brain
AI Buddy
Study one patient step by step across guideline packs, site practice, retrospective outcomes, access checks, and clinical-study routes before acting.
Open Patient File
Browse a searchable list of patients from your
department by visit status and date, then open any patient file in one click.
Go to Dashboard
Review cohort-level charts, treatment pathway funnels, geographic
spread, protocol adherence, and auto-generated insight cards.
Review Missed and High-Priority Patients
Jump straight to the surfaced critical and recommendation-level patients
requiring follow-up, documentation, or treatment acceleration.
Review Care Gaps
Go directly to the Quality & Care Gaps view to review missing
investigations, bone health gaps, and protocol adherence issues.
Add New Patient
Onboard a new patient into the registry and initialize their clinical
profile.
Department at a glance
Last Visit
2
Recently completed
Upcoming
2
Planned visits
Missed / Overdue
1
Needs follow-up
Population Alerts
7
Protocol insight cards
Cohort health
View full dashboard →
Protocol adherence score
73
/100
↓ 4 pts this month
Dropped due to bone protection gap (67% ADT patients
uncovered) and PSMA PET-CT not performed in 54% of high-risk staging.
Open care gaps
63
vs 57 last month
↑ 6 newthis month
Record completeness
68%
235 / 347 fully entered
↑ 3%from last month
New registrations
18
This month
→ stablevs 16 last
month
Cohort vs. NCCN benchmarks
Explore all metrics →ARSI intensification
29%our cohort vs60% NCCN
58 eligible patients not intensified. Generic abiraterone available.
PSMA PET-CT (high risk)
46%our cohort vs85% NCCN
31 high-risk staged without PSMA PET-CT.
Bone protection on ADT
33%our cohort vs85% NCCN
42 ADT patients with no zoledronate, denosumab, or Vit D.
MDT review rate
77%our cohort vs95% NCCN
Improved from 61% in 2024. Target ≥90% this quarter.
Nudge trends
Open quality view →
Nudge trend analysis
Bars show opened, viewed, acted upon, and resolved nudges. The line tracks net active nudges still requiring follow-up.
Cohort attention required
View care gaps →R.K. Sharma
DL-2024-08742
On ADT 4 months — no bone protection initiated. PSMA
PET-CT not done. Bone scan pending CGHS pre-auth.
PSA 42.6
cT3bN1M0
ISUP 4
S.N. Tiwari
UP-2025-0441
High-risk — no MDT review documented. Treatment started.
MDT sign-off or waiver documentation required. Stage cT3b, PSA 68.
PSA 68.1
cT3b
Very High
B.S. Rathod
RJ-2025-0637
Family history of breast cancer. Germline BRCA1/2 not
ordered. Eligible for PARP inhibitor if positive.
PSA 38.4
Gleason 4+4
High Risk
Showing 3 of 12 flagged
patients · View all →
Insight of the day
67% of patients on long-term ADT have no bone protection — the
largest single care gap in the cohort, affecting 42 patients at elevated fracture risk.
Auto-generated from cohort data · View in dashboard · Updated today
Care gap breakdown
Recently viewed patients
Incomplete records — data entry pending
112 records missing key
fields · Open full list →
Patient Files
Patients are organized by visit status and date. Use search to jump directly to a patient by name or UHID.
Last Visit 4
Upcoming 3
Missed / Overdue 2
Add Patient